These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20397967)

  • 1. P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.
    Lee CA; Cook JA; Reyner EL; Smith DA
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):603-19. PubMed ID: 20397967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution.
    Choong E; Dobrinas M; Carrupt PA; Eap CB
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):953-65. PubMed ID: 20504109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology.
    Carson SW; Ousmanou AD; Hoyler SL
    Psychopharmacol Bull; 2002; 36(1):67-81. PubMed ID: 12397848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
    Sun J; He ZG; Cheng G; Wang SJ; Hao XH; Zou MJ
    Med Sci Monit; 2004 Jan; 10(1):RA5-14. PubMed ID: 14704647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
    Marchetti S; Mazzanti R; Beijnen JH; Schellens JH
    Oncologist; 2007 Aug; 12(8):927-41. PubMed ID: 17766652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug.
    Fenner KS; Troutman MD; Kempshall S; Cook JA; Ware JA; Smith DA; Lee CA
    Clin Pharmacol Ther; 2009 Feb; 85(2):173-81. PubMed ID: 18987624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 gene polymorphisms and clinical relevance.
    Li YH; Wang YH; Li Y; Yang L
    Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of digoxin as a P-glycoprotein probe: implications of other transporters on sensitivity and specificity.
    Nader AM; Foster DR
    J Clin Pharmacol; 2014 Jan; 54(1):3-13. PubMed ID: 24166743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of P-glycoprotein for drug-drug interactions.
    Glaeser H
    Handb Exp Pharmacol; 2011; (201):285-97. PubMed ID: 21103973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs.
    Linnet K; Ejsing TB
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):157-69. PubMed ID: 17683917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the in vitro and in vivo critical parameters for P-glycoprotein, [I]/IC50 and [I2]/IC50, that allow for the exclusion of drug candidates from clinical digoxin interaction studies.
    Cook JA; Feng B; Fenner KS; Kempshall S; Liu R; Rotter C; Smith DA; Troutman MD; Ullah M; Lee CA
    Mol Pharm; 2010 Apr; 7(2):398-411. PubMed ID: 20025245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein in the placenta: expression, localization, regulation and function.
    Ceckova-Novotna M; Pavek P; Staud F
    Reprod Toxicol; 2006 Oct; 22(3):400-10. PubMed ID: 16563694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide does not interact with P-glycoprotein.
    Zimmermann C; Gutmann H; Drewe J
    Cancer Chemother Pharmacol; 2006 May; 57(5):599-606. PubMed ID: 16136308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of the MDR-1 gene.
    Mealey KL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):257-64. PubMed ID: 15500562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
    Hansen TS; Nilsen OG
    Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity.
    Madlova M; Bosquillon C; Asker D; Dolezal P; Forbes B
    J Pharm Pharmacol; 2009 Mar; 61(3):293-301. PubMed ID: 19222901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P-glycoprotein in statin drug interactions.
    Holtzman CW; Wiggins BS; Spinler SA
    Pharmacotherapy; 2006 Nov; 26(11):1601-7. PubMed ID: 17064205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary regulation of P-gp function and expression.
    Zhang W; Han Y; Lim SL; Lim LY
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):789-801. PubMed ID: 19545213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.